Table of Contents
Table of Contents 3
List of Tables 7
List of Figures 8
The Scripps Research Institute, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 9
The Scripps Research Institute, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 10
The Scripps Research Institute, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 11
The Scripps Research Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 12
The Scripps Research Institute, Medical Devices Deals, 2011 to YTD 2017 13
The Scripps Research Institute, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 14
The Scripps Research Institute, Pharmaceuticals & Healthcare, Deal Details 17
Partnerships 17
Pfizer Enters into Licensing Agreement with Scripps Research Institute 17
Transplant Genomics Enters into Licensing Agreement with Scripps Research Institute and Northwestern University 18
GeoVax Labs Enters into Agreement with Scripps Research Institute and Institute of Human Virology 19
HitGen Enters into Partnership with Scripps Research Institute and California Institute for Biomedical Research 20
Yisheng Biopharma Enters into Research Agreement with The Scripps Research Institute 21
Boehringer Ingelheim Enters into Research Agreement with Icahn School of Medicine, Massachusetts General Hospital, Scripps Research Institute and Weill Cornell Medicine 22
Scripps Research Institute, ZIP and IME Enter into Partnership 24
aTyr Pharma Enters into Agreement with Hong Kong University of Science and Technology, Scripps Research Institute and Stanford University for Human Proteins Discovery 25
Serina Therapeutics Enters Into Research Agreement With Scripps Research Institute 26
Scripps Research Institute Expands Research Agreement With Takeda 27
Proteostasis Therapeutics Enters Into Co-Development Agreement With Scripps Research Institute 28
Scripps Research Institute Enters Into Research Agreement With Bristol-Myers Squibb 29
ChromaDex Enters Into Co-Development Agreement With Scripps Research Institute 30
Jupiter Medical Center Enters Into Research Agreement With The Scripps Research Institute 31
LEO Pharma Enters Into Research Collaboration With The Scripps Research Institute 32
Molecular Response Enters Into An Agreement With Scripps Translational Science Institute 33
Scripps Research Enters Into Joint Venture Agreement With Vanderbilt University 34
Licensing Agreements 35
ChromaDex Enters into Licensing Agreement with Scripps Research Institute 35
iGenomX Enters into Licensing Agreement with Scripps Research Institute 36
OPKO Health Enters into Licensing Agreement with Scripps Research Institute 37
Scripps Research Institute Enters into Licensing Agreement with T23 Biopharma for CD22 38
Cempra Enters into License Agreement with Scripps Research Institute 39
BlinkBio Enters into Option agreement with Scripps Research Institute 40
Corvus Pharma Enters into Licensing Agreement with Scripps Research Institute 41
Padlock Therapeutics Enters into Licensing Agreement with Scripps Research Institute 42
Fabrus Enters into Licensing Agreement with Scripps Research Institute 43
Verastem Enters Into Licensing Agreement With Scripps Research Institute For VS-4718 44
Zebra Biologics Enters into Licensing Agreement with Scripps Research Institute 46
Sorrento Therapeutics Enters Into Licensing Agreement With Scripps Research Institute 47
Sigma-Aldrich Enters Into Licensing Agreement With Scripps Research Institute For Research Reagents 48
Janssen Pharma Enters Into Licensing Agreement With Scripps Research Institute For Infectious Diseases 49
Serina Therapeutics Enters Into License Agreement With Scripps Research Institute For Click Chemistry 50
Sutro Biopharma Enters Into Licensing Agreement With Scripps Research Institute For Click Chemistry 51
OPKO Health Enters Into Licensing Agreement With Scripps Research Institute For SR 3306 52
Integrated Diagnostics Enters Into Licensing Agreement With The Scripps Research Institute 53
Equity Offering 54
Blackthorn Therapeutics Spin Off from Scripps Research Institute 54
The Scripps Research Institute – Key Competitors 55
The Scripps Research Institute – Key Employees 56
The Scripps Research Institute – Locations And Subsidiaries 57
Head Office 57
Other Locations & Subsidiaries 57
Joint Venture 57
Recent Developments 59
Corporate Communications 59
Jun 01, 2016: TSRI Appoints Richard King as Chief Operating Officer 59
Government and Public Interest 60
Nov 16, 2017: Scripps Research Institute: New Painkillers Reduce Overdose Risk 60
Nov 02, 2017: Researchers Find Protein that Could Help Fight Antibiotic Resistance 61
Oct 27, 2017: Johns Hopkins Partnering with Other Institutions to Create a National Center for Health Data 62
Oct 25, 2017: New Study ‘Double Decker’ Antibody Technology Fights Cancer 63
Oct 16, 2017: Einstein Researchers Share $9 Million Grant to Find Anti-Aging Therapies 64
Oct 16, 2017: Scripps Florida Scientists Share $9 Million Grant to Develop Therapies that Target the Aging Process 65
Oct 04, 2017: HIVE Center Receives $27 Million in NIGMS Funding to Advance HIV Research 66
Oct 02, 2017: TSRI Researchers Join National Digital Health Informatics Collaborative 67
Sep 28, 2017: Scientists Develop Broad-Spectrum Inhibitors of Influenza Viruses 68
Sep 19, 2017: Scripps Florida Scientist Awarded $2.5 Million Collaborative Grant to Develop New Diabetes Treatment 70
Sep 11, 2017: Outside-In Reprogramming: Antibody Study Suggests a Better Way to Make Stem Cells 71
Sep 07, 2017: Scripps Florida Scientists Confirm Quality Control Mechanism to Protect Protein Production 73
Aug 17, 2017: TSRI Awarded $11 Million Grant Renewal by NIAID for Long-Running Study of Immunity, Inflammation 74
Aug 07, 2017: TSRI Chemists Develop Inexpensive, Versatile Technique for Making RNA 76
Jul 31, 2017: Scripps Florida Scientists Identify Protein Deficiency Involved in Childhood Anemia and Cancers 78
Jul 31, 2017: Protein Profiling Method Reveals Many Potential New Drug Targets 79
Jun 15, 2017: Scripps Florida Scientist and Collaborators Win $7 Million Grant to Develop New ALS Treatments 81
Jun 14, 2017: Influenza Virus Can Overcome Potentially Crippling Mutations 82
Jun 06, 2017: TSRI Anti-Heroin Vaccine Found Effective in Non-Human Primates 84
May 31, 2017: Scripps Florida Scientist Wins $2 Million Grant to Study Childhood Disorder Linked to Behavioral Problems 85
May 29, 2017: New Antibiotic Packs a Punch Against Bacterial Resistance 86
May 24, 2017: TSRI Scientists Find Simple Copper Complex Shuts Down Botulinum Neurotoxin Poisoning 87
May 04, 2017: Scientists Solve Major Cancer Protein Conundrum 89
Apr 14, 2017: TSRI Chemists Devise Simple Method for Making Sought-After Boronic Acid-Based Drugs and Other Products 90
Mar 27, 2017: Scientists discover new class of anti-diabetes compounds that reduce liver glucose production 92
Feb 14, 2017: Scripps Florida Collaboration Awarded $3.3 Million to Develop Next-Generation Breast Cancer Therapies 93
Feb 07, 2017: Cystinosis Research Foundation Grants Support Scientific Studies on Cell Function, New Treatments and the Quest for a Cure 94
Jan 30, 2017: New TSRI Study Shows Early Brain Changes in Fragile X Syndrome 96
Jan 24, 2017: Scripps Florida team awarded $1.8 million grant to develop drugs for heart disease and rheumatoid arthritis 97
Dec 29, 2016: Scripps Florida scientists uncover new way to defeat therapy-resistant prostate cancer 98
Dec 22, 2016: TSRI study: Protein monitors lung volume and regulates breathing 99
Dec 12, 2016: Study shows aging process increases DNA mutations in important type of stem cell 101
Dec 07, 2016: Scripps Florida Scientists Uncover Potential Driver of Age- and Alzheimer’s-Related Memory Loss 102
Oct 17, 2016: Scripps Florida Scientists Uncover New Facets of Zika-Related Birth Defects to Help Develop Treatment 103
Oct 13, 2016: Scripps Florida Scientists Awarded Special Grant to Develop Memory-Altering Medication for Addiction 104
Oct 12, 2016: Scientists Identify Potent New Anti-Obesity, Anti-Diabetes Target 105
Oct 05, 2016: Grant to TSRI-Led Consortium Expands to $207 Million 106
Sep 12, 2016: TSRI scientists discover antibodies that target holes in HIV’s defenses 107
Sep 08, 2016: New Vaccination Strategies Successfully Coach Immune System to Make Powerful HIV-Neutralizing Antibodies 108
Sep 01, 2016: New TSRI Method Makes Building ‘One-Handed’ Drugs Easier than Ever 110
Aug 11, 2016: New Study Shines Light on Mutations Responsible for Debilitating Heart Conditions 112
Aug 02, 2016: TSRI Researchers Find ‘Lead Actors’ in Immune Cell Development 113
Aug 01, 2016: A Potential New Way to Sway the Immune System 115
Jul 20, 2016: TSRI team finds potential drug candidates that could intervene in deadly diseases 116
Jul 07, 2016: Walgreens to Participate in U.S. Precision Medicine Initiative Cohort Program through The Scripps Research Institute 118
Jul 06, 2016: NIH awards $55 million to build million-person precision medicine study 119
Jun 28, 2016: TSRI scientists stabilize HIV structure, design potential AIDS vaccine candidates 121
Jun 27, 2016: TSRI scientists find new cancer drug target in dual-function protein 123
Jun 23, 2016: TSRI Scientists Reveal Single-Neuron Gene Landscape of the Human Brain 124
Jun 15, 2016: New TSRI Method Opens Door to Development of Many New Medicines 126
Jun 07, 2016: Scripps Florida Scientists Awarded $1.3 Million to Optimize Chemical Probes to Test an Innovative Approach to Cancer Treatment 128
May 26, 2016: TSRI Scientists Discover Mechanism that Turns Mutant Cells into Aggressive Cancers 129
May 09, 2016: Scripps Florida scientists pioneer a breakthrough approach to breast cancer treatment 130
Apr 27, 2016: TSRI, Harvard, Stanford and Brandeis Collaborate to Study MicroRNA’s Role in Memory, Sleep and Synapse Function 131
Apr 21, 2016: New Molecule-Building Method from TSRI Opens Up Vast Realm of Chemistry for Pharma and Other Industries 132
Apr 14, 2016: Scripps Florida Study Identifies Memory Suppressor Gene That Could Hold Key to New Alzheimer’s Disease Treatments 134
Apr 05, 2016: TSRI scientists get first-ever glimpse of ‘teenage’ HIV-neutralizing antibody 135
Apr 04, 2016: TSRI Scientists: Immune Cell Transforms from ‘Clark Kent’ to ‘Superman’ 137
Mar 31, 2016: Scripps Florida Team Awarded $3.4M to Develop Treatments for Addiction, Mood Disorders 138
Mar 28, 2016: TSRI, Salk Scientists Discover ‘Outlier’ Enzymes that Could Offer New Targets to Treat Diabetes, Inflammation 139
Mar 18, 2016: Scripps Florida Scientists Win $1.4 Million Grant to Develop New Ways to Block Breast Cancer 141
Mar 10, 2016: TSRI study identifies new type of protein clump that may be implicated in ALS 142
Mar 09, 2016: Scripps Florida study lays groundwork for potential bipolar disorder therapies 144
Mar 08, 2016: Scripps Florida Scientists Win $2.4 Million to Develop New Strategies to Fight Obesity 145
Feb 29, 2016: Scripps Florida Scientists Find Way to Predict Activity of Stem Cells 146
Feb 24, 2016: Scripps Florida Scientists Awarded $2.25 Million to Study Key Mechanisms Behind Some Cancers 147
Feb 19, 2016: TSRI and JCVI scientists find popular stem cell techniques safe 148
Feb 18, 2016: Researchers discover new Ebola-fighting antibodies in blood of outbreak survivor 149
Feb 16, 2016: TSRI Scientists Create Vaccine Against Dangerous Designer Opioids 151
Feb 12, 2016: Scripps Florida Scientists Win $1.7 Million Grant to Advance New Strategies to Treat Huntington’s Disease 152
Feb 11, 2016: Scripps Florida scientists identify a memory suppressor that may play a role in autism 153
Feb 03, 2016: Scripps Florida Scientists Win $1.2 Million to Study New Strategies for Treating Obesity, Diabetes, Cardiovascular Disease and Muscle Decline 154
Jan 27, 2016: Philanthropist Samuel Yin Provides $12.8 Million Gift for New Laboratories at The Scripps Research Institute 155
Jan 25, 2016: Crouching Protein, Hidden Enzyme : The Scripps Research Institute 156
Jan 14, 2016: TSRI Researchers Develop Versatile New Way to Build Molecules 158
Jan 12, 2016: TSRI Chemists Awarded $2.1 Million to Create Potential New Therapies with Click Chemistry 160
Product News 161
Dec 29, 2016: Scripps Florida scientists develop drug discovery approach to predict health impact of endocrine-disruptors 161
Dec 20, 2016: Scripps Florida scientists discover new natural source of potent anti-cancer drugs 163
Dec 12, 2016: TSRI scientists devise new approaches to personalized medicines 164
Nov 21, 2016: Scripps Florida Scientists Create Innovative Drug Design Strategy to Improve Breast Cancer Treatment 165
Nov 07, 2017: Researchers Discover Promising New Anticancer Strategy 166
Oct 26, 2017: Vanderbilt leads international effort to develop universal flu vaccine 168
Sep 04, 2017: Scripps Florida Scientists Identify Compounds That Significantly Increase Healthy Aging 169
Aug 16, 2017: TSRI Researchers Find a Way to Combat Pharmacoterrorism 170
May 19, 2016: New HIV-Mimicking Particles That Trigger Immune Response Could Advance AIDS Vaccine Design 172
Mar 31, 2016: TSRI-Calibr Team Creates Novel Platform for Generating Long-Acting Drug Candidates 173
Mar 28, 2016: A Novel Peptide Engineering Platform for Generating Stapled Long-acting Peptide Hormones 174
Mar 24, 2016: New findings in humans provide encouraging foundation for upcoming AIDS vaccine clinical trial 175
Mar 23, 2016: TSRI Chemists Find a Way to Synthesize Complex Plant Molecule Phorbol and Its Derivatives 177
03/16/2017: Scripps Florida scientists develop new drug delivery method for cancer therapy 179
Mar 09, 2017: Potential drug candidates halt prostate and breast cancer growth 180
Jan 28, 2016: TSRI Study Reveals Workings of Mysterious ‘Relief Valve’ that Protects Cells from Swelling 182
Jan 14, 2016: TSRI Chemists Devise Powerful New Method for Modifying Drug Molecules 184
Jan 14, 2016: California Institute for Biomedical Research releases a pair of research articles describing a novel switchable CAR-T cell platform to treat cancer 186
Other Significant Developments 187
Oct 26, 2017: The Human Vaccines Project Launches New Initiative To Accelerate Development Of Universally Effective Influenza Vaccines 187
Appendix 188
Methodology 188
About GlobalData 188
Contact Us 188
Disclaimer 188
The Scripps Research Institute, Pharmaceuticals & Healthcare, Key Facts 2
The Scripps Research Institute, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 9
The Scripps Research Institute, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 10
The Scripps Research Institute, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 11
The Scripps Research Institute, Deals By Therapy Area, 2011 to YTD 2017 12
The Scripps Research Institute, Medical Devices Deals, 2011 to YTD 2017 13
The Scripps Research Institute, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 14
Pfizer Enters into Licensing Agreement with Scripps Research Institute 17
Transplant Genomics Enters into Licensing Agreement with Scripps Research Institute and Northwestern University 18
GeoVax Labs Enters into Agreement with Scripps Research Institute and Institute of Human Virology 19
HitGen Enters into Partnership with Scripps Research Institute and California Institute for Biomedical Research 20
Yisheng Biopharma Enters into Research Agreement with The Scripps Research Institute 21
Boehringer Ingelheim Enters into Research Agreement with Icahn School of Medicine, Massachusetts General Hospital, Scripps Research Institute and Weill Cornell Medicine 22
Scripps Research Institute, ZIP and IME Enter into Partnership 24
aTyr Pharma Enters into Agreement with Hong Kong University of Science and Technology, Scripps Research Institute and Stanford University for Human Proteins Discovery 25
Serina Therapeutics Enters Into Research Agreement With Scripps Research Institute 26
Scripps Research Institute Expands Research Agreement With Takeda 27
Proteostasis Therapeutics Enters Into Co-Development Agreement With Scripps Research Institute 28
Scripps Research Institute Enters Into Research Agreement With Bristol-Myers Squibb 29
ChromaDex Enters Into Co-Development Agreement With Scripps Research Institute 30
Jupiter Medical Center Enters Into Research Agreement With The Scripps Research Institute 31
LEO Pharma Enters Into Research Collaboration With The Scripps Research Institute 32
Molecular Response Enters Into An Agreement With Scripps Translational Science Institute 33
Scripps Research Enters Into Joint Venture Agreement With Vanderbilt University 34
ChromaDex Enters into Licensing Agreement with Scripps Research Institute 35
iGenomX Enters into Licensing Agreement with Scripps Research Institute 36
OPKO Health Enters into Licensing Agreement with Scripps Research Institute 37
Scripps Research Institute Enters into Licensing Agreement with T23 Biopharma for CD22 38
Cempra Enters into License Agreement with Scripps Research Institute 39
BlinkBio Enters into Option agreement with Scripps Research Institute 40
Corvus Pharma Enters into Licensing Agreement with Scripps Research Institute 41
Padlock Therapeutics Enters into Licensing Agreement with Scripps Research Institute 42
Fabrus Enters into Licensing Agreement with Scripps Research Institute 43
Verastem Enters Into Licensing Agreement With Scripps Research Institute For VS-4718 44
Zebra Biologics Enters into Licensing Agreement with Scripps Research Institute 46
Sorrento Therapeutics Enters Into Licensing Agreement With Scripps Research Institute 47
Sigma-Aldrich Enters Into Licensing Agreement With Scripps Research Institute For Research Reagents 48
Janssen Pharma Enters Into Licensing Agreement With Scripps Research Institute For Infectious Diseases 49
Serina Therapeutics Enters Into License Agreement With Scripps Research Institute For Click Chemistry 50
Sutro Biopharma Enters Into Licensing Agreement With Scripps Research Institute For Click Chemistry 51
OPKO Health Enters Into Licensing Agreement With Scripps Research Institute For SR 3306 52
Integrated Diagnostics Enters Into Licensing Agreement With The Scripps Research Institute 53
Blackthorn Therapeutics Spin Off from Scripps Research Institute 54
The Scripps Research Institute, Key Competitors 55
The Scripps Research Institute, Key Employees 56
The Scripps Research Institute, Other Locations 57
The Scripps Research Institute, Subsidiaries 57
The Scripps Research Institute, Joint Venture 57
